Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.400 Biomarker disease PSYGENET Results suggest that antidepressant treatment of depression can be optimized by the clinical application of ABCB1 genotyping. 23880209 2014
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.400 GeneticVariation disease BEFREE P-glycoprotein (PGP) polymorphisms and sexual dysfunction in female patients with depression and SSRI-associated sexual side effects. 23356581 2013
Entrez Id: 85320
Gene Symbol: ABCC11
ABCC11
0.010 Biomarker disease BEFREE In the present work, we explored the potential role of Mrp8/14 in the progression of depression. 30180864 2018
Entrez Id: 6833
Gene Symbol: ABCC8
ABCC8
0.010 Biomarker disease BEFREE In the present work, we explored the potential role of Mrp8/14 in the progression of depression. 30180864 2018
Entrez Id: 10060
Gene Symbol: ABCC9
ABCC9
0.020 PosttranslationalModification disease BEFREE These findings add further support for the involvement of calcium channels in the mechanisms regulating sleep function and suggest a possible role of the ABCC9 gene in depression. 23780892 2013
Entrez Id: 10060
Gene Symbol: ABCC9
ABCC9
0.020 GeneticVariation disease BEFREE More common brain disorders linked to ABCC9 gene variants include hippocampal sclerosis of aging (HS-Aging), sleep disorders, and depression. 26226329 2015
Entrez Id: 25
Gene Symbol: ABL1
ABL1
0.020 Biomarker disease BEFREE ROS-activated ABL1 mediates inflammation through regulating NF-<i>κ</i>B1 and STAT3, which subsequently leads to the development of GC and GC-related depression. 31396300 2019
Entrez Id: 25
Gene Symbol: ABL1
ABL1
0.020 Biomarker disease BEFREE In this review, we examine the evidence to illuminate the molecular mechanism of ABL1 in the progression of GC patients with depression and identify out new and effective methods for the initial and long‑term treatment of GC. 27666407 2016
Entrez Id: 31
Gene Symbol: ACACA
ACACA
0.010 Biomarker disease BEFREE However we also found that increased dmPFC connectivity with the ACC/paracingulate gyrus related to anhedonia whereas increased RSFC with the frontal pole related to depression severity. 30260258 2018
Entrez Id: 27034
Gene Symbol: ACAD8
ACAD8
0.070 Biomarker disease BEFREE The main goal of this systematic literature review was summarize the evidence on the utilization and effectiveness of treatments for depression and anxiety in persons with IBD. 28867427 2017
Entrez Id: 27034
Gene Symbol: ACAD8
ACAD8
0.070 Biomarker disease BEFREE We assessed the impact of depression and antidepressant therapies on the development of IBD. 30337374 2019
Entrez Id: 27034
Gene Symbol: ACAD8
ACAD8
0.070 Biomarker disease BEFREE The disease burden is very high in IBD, with poor QoL, fatigue, work impairment, and depression in half of patients. 27516406 2017
Entrez Id: 27034
Gene Symbol: ACAD8
ACAD8
0.070 Biomarker disease BEFREE Anxiety and depression are associated with lower cognitive function in MS, with a similar pattern observed in persons with other IMID, including IBD and RA, and persons without an IMID. 30635487 2019
Entrez Id: 27034
Gene Symbol: ACAD8
ACAD8
0.070 Biomarker disease BEFREE Quantifiable differences in health care costs and patterns of use exist among patients with IBD and depression. 30256923 2019
Entrez Id: 27034
Gene Symbol: ACAD8
ACAD8
0.070 Biomarker disease BEFREE These findings can be used to design information resources to meet information needs regarding depression in MS, IBD and RA. 30982700 2019
Entrez Id: 27034
Gene Symbol: ACAD8
ACAD8
0.070 Biomarker disease BEFREE It is recommended that adolescents with IBD ages 12 and older be screened for depression annually. 31568153 2020
Entrez Id: 84680
Gene Symbol: ACCS
ACCS
0.040 Biomarker disease BEFREE Plasma homocysteine could be a biomarker for depressive disorder particularly in the acute phase of ACS. 27626182 2016
Entrez Id: 84680
Gene Symbol: ACCS
ACCS
0.040 GeneticVariation disease BEFREE ACS patients with higher NR3C1 1 F exon methylation levels were at higher risk of developing depressive disorder within 2 weeks of ACS. 30408722 2019
Entrez Id: 84680
Gene Symbol: ACCS
ACCS
0.040 Biomarker disease BEFREE <b>Methods:</b> A total of 100 stroke survivors were recruited from five metropolitan hospitals and assessed at 3- and 12-months post-stroke using measures of activity participation (Activity Card Sort-Australia (ACS-Aus)) and depressive symptoms (Montgomery-Asberg Depression Rating Scale Structured Interview Guide (MADRS-SIGMA)). 29889570 2019
Entrez Id: 84680
Gene Symbol: ACCS
ACCS
0.040 Biomarker disease BEFREE MACE incidence was significantly higher in patients with depressive disorder at early or late phase of ACS than those without, regardless of status at the other time point; however, highest incidence was found following depression at both time points. 31541969 2020
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.400 GeneticVariation disease BEFREE Genetic variants in the angiotensin I-converting-enzyme (ACE) and angiotensin II receptor (AT1) gene and clinical outcome in depression. 15949885 2005
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.400 GeneticVariation disease BEFREE Intervening on maternal depression among mothers with chronic pain may reduce the impact of intergenerational ACE transmission. 31005595 2019
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.400 GeneticVariation disease BEFREE Four of nine variants within ACE were nominally associated with depression and a gene-wise association was likewise observed. 27264499 2017
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.400 GeneticVariation disease BEFREE Variants of the ACE gene influence cortisol secretion and appear as susceptibility factors for late-life depression in the elderly population. 24193727 2013
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.400 GeneticVariation disease BEFREE The aim of the present study was to examine the influence of the well-known polymorphisms rs1799752 in the angiotensin-converting enzyme (ACE) and rs5186 in the angiotensin receptor II type 1 (AGTR1) on late-life depression and dementia in a population-based Swedish cohort of older individuals followed over 12 years. 27639288 2017